// App-Quantinova.ai

409 : Immunofluorescent digital slide technology to evaluate correlation between Glypican-3 expression and response to codrituzumab

Researchers

Presenter

  • Takayoshi Tanaka

Principal Investigators

  • Yasuo Sugitani

  • Tokiya Abe

  • Miho Kawaida

  • Ken Yamazaki

  • Akinori Hashiguchi

  • Michiie Sakamoto

  • Toshihiko Ohtomo

Medical Centers

  • Taiho Pharmaceutical Co., LTD., Tokyo, Japan

  • Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Glypican-3

Drug/Treatment

  • Codrituzumab

  • GC33

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved